The abstract is read at the publisher; the summary is JClub's.
Thermostable Group II Intron Reverse Transcriptase sequencing in human cells, extracellular vesicles, and plasma identified a novel class of short (<300 nt) largely structured Full-Length EXcised linear Intron RNAs.
- Why it matters: Mobile group II intron reverse transcriptases are widespread and diversified, but their biochemical capabilities and how they can reveal RNA regulation and disease-linked RNAs in humans remained to be fully leveraged.
- What they did: The authors developed a comprehensive RNA sequencing method using Thermostable Group II Intron Reverse Transcriptases, then mapped sequencing reads to genome and transcriptome references to compute intron/exon depth ratios and profile transcriptional versus post-transcriptional regulation.
- The result: In inflammatory breast cancer patient tumors and peripheral blood mononuclear cells, RNAs with high intron/exon depth ratios were linked to plasma-detected pre-mRNA and intron fragments and included the first potential inflammatory breast cancer biomarkers.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.